19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Umberto Basso is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 218 Article
  • 5 Review article
  • 1 Conference contribution

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database

Delanoy, N., Hardy-Bessard, A-C., Efstathiou, E., Le Moulec, S., Basso, U., Birtle, A., Thomson, A., Krainer, M., Guillot, A., De Giorgi, U., Hasbini, A., Daugaard, G., Bahl, A., Chowdhury, S., Caffo, O., Beuzeboc, P., Spaeth, D., Eymard, J-C., Fléchon, A., Alexandre, J. & 17 others, Helissey, C., Butt, M., Priou, F., Lechevallier, E., Deville, J-L., Gross-Goupil, M., Morales, R., Thiery-Vuillemin, A., Gavrikova, T., Barthélémy, P., Sella, A., Fizazi, K., Ferrero, J-M., Laguerre, B., Thibault, C., Hans, S. & Oudard, S., Jan 2020, In : Eur. J. Cancer. 125, p. 153-163 11 p.

Research output: Contribution to journalArticle

  • Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy

    Banna, G. L., Di Quattro, R., Malatino, L., Fornarini, G., Addeo, A., Maruzzo, M., Urzia, V., Rundo, F., Lipari, H., De Giorgi, U. & Basso, U., Jan 1 2020, (Accepted/In press) In : Clinical and Translational Oncology.

    Research output: Contribution to journalArticle

  • Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors

    Santoni, M., Heng, D. Y., Bracarda, S., Procopio, G., Milella, M., Porta, C., Matrana, M. R., Cartenì, G., Crabb, S. J., De Giorgi, U., Basso, U., Masini, C., Calabrò, F., Vitale, M. G., Santini, D., Massari, F., Galli, L., Fornarini, G., Ricotta, R., Buti, S. & 29 others, Zucali, P., Caffo, O., Morelli, F., Carrozza, F., Martignetti, A., Gelibter, A., Iacovelli, R., Mosca, A., Atzori, F., Vau, N., Incorvaia, L., Ortega, C., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Paolucci, V., Graham, J., Pierce, E., Scagliarini, S., Sepe, P., Verzoni, E., Merler, S., Rizzo, M., Sorgentoni, G., Conti, A., Piva, F., Cimadamore, A., Montironi, R. & Battelli, N., Jan 2020, In : Cancers. 12, 1, 84.

    Research output: Contribution to journalArticle

    Open Access
  • Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

    Caffo, O., Facchini, G., Biasco, E., Ferraù, F., Morelli, F., Donini, M., Buttigliero, C., Calvani, N., Guida, A., Chiuri, V. E., Basso, U., Mucciarini, C., Conteduca, V., Rossetti, S., Veccia, A., Maines, F., Kinspergher, S. & De Giorgi, U., 2019, In : Future Oncology. 15, 10, p. 1115-1123 9 p.

    Research output: Contribution to journalArticle

    Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

    Caffo, O., Facchini, G., Biasco, E., Ferraù, F., Morelli, F., Donini, M., Buttigliero, C., Calvani, N., Guida, A., Chiuri, V. E., Basso, U., Mucciarini, C., Conteduca, V., Rossetti, S., Veccia, A., Maines, F., Kinspergher, S. & De Giorgi, U., Mar 19 2019, In : Future Oncology. p. 1115-1123 8 p.

    Research output: Contribution to journalArticle